Dynamic and detail-oriented pharmaceutical scientist with a robust history of successful product development and innovative research methodologies. Demonstrates expertise in formulation, testing, and optimizing pharmaceutical drug products, prioritizing regulatory compliance and quality assurance. Proven track record in leading cross-functional teams, enhancing production efficiency, and contributing to significant advancements in pharmaceutical sciences. Adept at managing complex projects from conceptualization through to completion.
Responsible for observing, cultivating quality, and compliance targets.
Honored Member of the Rho-Chi Society- Beta Theta Chapter
LIU-AAPS Student Chapter, Chair 2018-2019
FPGEC Certified by National Association of Boards of Pharmacy
NAPLEX will be taken by the end of May, 2022
1. Nasser, H., DAVE, R. (2019). “A Comparison of the Economical and Experimental Outcomes of Different Ratios and Types of Fillers in Direct Compression Process of Solid Dosage Form in order to Evaluate the Critical Quality Attributes of Glucosamine Tablets.”
2. Nasser, H., DAVE, R. (2018). “The Impact of Different Granulation Processes such as Wet Granulation and Hot Melt Granulation of Hydroxypropyl Cellulose, HPC-SSL/SFP on the Physical and Mechanical Properties of Ibuprofen Tablets.”
3. Nasser, H., DAVE, R. (2017). “To Determine the End-point of Different Ratios of Liquid Binder During High and Low Shear Wet Granulation Processes by Measuring Thermal and Rheological Properties.”
Hiking
Reading
Fitness